Transdermal pharmaceutical formulation for minimizing skin residues

Details for Australian Patent Application No. 2004283431 (hide)

Owner Antares Pharma IPL AG

Inventors Grenier, Arnaud; Besse, Celine; R. Carrara, Dario Norberto

Agent Cullen & Co

Pub. Number AU-B-2004283431

PCT Pub. Number WO2005/039531

Priority 60/510,613 10.10.03 US

Filing date 6 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 10 September 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/039531 Priority application(s): WO2005/039531

10 September 2009 Application Accepted

  Published as AU-B-2004283431

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283432-Microemulsions of retinoids, and pharmaceutical compositions containing them

2004283430-p185neu-encoding DNA and therapeutical uses thereof